Daily supplements of B vitamins for people with high homocysteine
levels do not affect cognitive performance compared to placebo,
says a new study from New Zealand.
People genetically prone to high concentrations of homocysteine
have a higher risk of stroke than other individuals, according to a
new study that supports the theory of a causal relationship between
the amino acid and stroke.
Elderly people could gain some protection against cognitive decline
by taking B vitamins to reduce levels of homocysteine, after
researchers find the amino acid is a modest predictor of mental
performance.
Folic acid, found to lower plasma homocysteine levels, did not
prevent heart attacks and strokes in heart disease patients
receiving supplements of the vitamin, report researchers in the
Netherlands.
Researchers at Wageningen University say that people with a
genetically determined, reduced breakdown of the amino acid
homocysteine have an increased risk of coronary heart disease but
that the reduced homocysteine breakdown only...
Elevated levels of the amino acid homocysteine in the blood can
lead to a higher risk of dementia, including Alzheimer's-related
dementia, according to the February 14th issue of The New England
Journal of Medicine.
